Skip to content

RegenoCELL Therapeutics, Inc.

company.status.inactive

CIK 1221749fmd_03AKZSNXZRVQ7N2TVCSJK9C3Z1Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Dec 31, 2011, 6 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011
Total revenues11
Cost of revenue00
Gross profit11
Total operating expenses42
Operating income(4)(1)
Interest expense00
Other non-operating income (expense)(0)(0)
Income before taxes(4)(1)
Income tax expense00
Net income from continuing operations(4)(1)
Net income(4)(1)